Application of Machine Learning Based on fNIRS in Predicting Acupuncture's Efficacy in Treating Tinnitus
Launched by THE THIRD AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIVERSITY · Apr 12, 2024
Trial Information
Current as of September 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how machine learning can help predict whether acupuncture will be effective for people suffering from tinnitus, a condition that causes ringing or buzzing in the ears. Researchers will analyze brain imaging data from participants to create a model that could better understand how acupuncture might help those with this condition.
To be part of this study, participants must be between 18 and 60 years old, have chronic tinnitus in both ears, and be right-handed. They should not be involved in other clinical trials or have any serious health issues that could affect the results. Participants can expect to undergo some brain imaging tests and acupuncture treatments as part of the study. If you or someone you know is interested and meets the eligibility criteria, this could be an opportunity to help advance research in treating tinnitus.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Bilateral tinnitus that meets the diagnostic criteria for chronic subjective tinnitus.
- • Male and female, aged between 18 and 60 years.
- • Right-handed subjects who are able to comply with the study protocol and sign written informed consent.
- • Not participating in other clinical trials concurrently.
- Exclusion Criteria:
- • Participants with objective tinnitus.
- • Participants have nervous system diseases or neuropsychiatric diseases that can significantly affect brain blood oxygen metabolism assessed by fNIRS.
- • Participants with severe cardiovascular and cerebrovascular diseases, malignant liver and kidney diseases, and other serious diseases.
- • Participants have any contraindications for acupuncture (such as a bleeding tendency).
- • Pregnant or lactating women.
- • Participants have received tinnitus treatment with drugs or other therapies in the last four weeks.
About The Third Affiliated Hospital Of Zhejiang Chinese Medical University
The Third Affiliated Hospital of Zhejiang Chinese Medical University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. With a strong focus on patient-centered care, the hospital integrates advanced medical practices with comprehensive educational programs. As a prominent sponsor of clinical trials, it aims to contribute to the development of new therapies and treatment protocols, fostering collaboration among researchers, healthcare professionals, and academic institutions. The hospital's commitment to rigorous scientific inquiry and ethical standards ensures the integrity and reliability of its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Trial Officials
Hantong Hu, M.D
Principal Investigator
The Third Affiliated hospital of Zhejiang Chinese Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported